120 related articles for article (PubMed ID: 18511879)
1. Involvement of corticotropin-releasing factor receptor 2 beta in differentiation of dopaminergic MN9D cells.
Jin TE; Jang M; Kim H; Choi YM; Cho H; Chung S; Park MK
Mol Cells; 2008 Sep; 26(3):243-9. PubMed ID: 18511879
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways.
Cibelli G; Corsi P; Diana G; Vitiello F; Thiel G
Eur J Neurosci; 2001 Apr; 13(7):1339-48. PubMed ID: 11298794
[TBL] [Abstract][Full Text] [Related]
3. Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells.
Kim Y; Park MK; Uhm DY; Chung S
Biochem Biophys Res Commun; 2007 Jul; 358(3):796-801. PubMed ID: 17506983
[TBL] [Abstract][Full Text] [Related]
4. The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway.
Traver S; Marien M; Martin E; Hirsch EC; Michel PP
Mol Pharmacol; 2006 Jul; 70(1):30-40. PubMed ID: 16569708
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice.
Todorovic C; Sherrin T; Pitts M; Hippel C; Rayner M; Spiess J
Neuropsychopharmacology; 2009 May; 34(6):1416-26. PubMed ID: 18843268
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing factor induces phosphorylation of phospholipase C-gamma at tyrosine residues via its receptor 2beta in human epidermoid A-431 cells.
Kiang JG; Ding XZ; Gist ID; Jones RR; Tsokos GC
Eur J Pharmacol; 1998 Dec; 363(2-3):203-10. PubMed ID: 9881591
[TBL] [Abstract][Full Text] [Related]
7. Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes.
Chandras C; Koutmani Y; Kokkotou E; Pothoulakis C; Karalis KP
Endocrinology; 2009 Oct; 150(10):4606-14. PubMed ID: 19628576
[TBL] [Abstract][Full Text] [Related]
8. Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling.
Jonassen AK; Wergeland A; Helgeland E; Mjøs OD; Brar BK
Regul Pept; 2012 Feb; 174(1-3):90-7. PubMed ID: 22209828
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between dopamine D1 and corticotropin releasing factor type 2 receptors leads to occlusion of their ERK1/2 signaling.
Yarur HE; González MP; Verbel-Vergara D; Andrés ME; Gysling K
J Neurochem; 2020 Nov; 155(3):264-273. PubMed ID: 32215915
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of calbindin-D28K induces neurite outgrowth in dopaminergic neuronal cells via activation of p38 MAPK.
Choi WS; Chun SY; Markelonis GJ; Oh TH; Oh YJ
Biochem Biophys Res Commun; 2001 Sep; 287(3):656-61. PubMed ID: 11563845
[TBL] [Abstract][Full Text] [Related]
11. A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor.
Valdenaire O; Giller T; Breu V; Gottowik J; Kilpatrick G
Biochim Biophys Acta; 1997 May; 1352(2):129-32. PubMed ID: 9199241
[TBL] [Abstract][Full Text] [Related]
12. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
[TBL] [Abstract][Full Text] [Related]
13. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
Brar BK; Jonassen AK; Egorina EM; Chen A; Negro A; Perrin MH; Mjøs OD; Latchman DS; Lee KF; Vale W
Endocrinology; 2004 Jan; 145(1):24-35; discussion 21-3. PubMed ID: 12970163
[TBL] [Abstract][Full Text] [Related]
14. The calcineurin-nuclear factor of activated T cells signaling pathway mediates the effect of corticotropin releasing factor and urocortins on catecholamine synthesis.
Dermitzaki E; Tsatsanis C; Gravanis A; Margioris AN
J Cell Physiol; 2012 May; 227(5):1861-72. PubMed ID: 21702050
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.
Kageyama K; Hanada K; Moriyama T; Imaizumi T; Satoh K; Suda T
Mol Cell Endocrinol; 2007 Jan; 263(1-2):90-102. PubMed ID: 17027144
[TBL] [Abstract][Full Text] [Related]
16. Stress and glucocorticoids regulated corticotropin releasing factor in rat prefrontal cortex.
Meng QY; Chen XN; Tong DL; Zhou JN
Mol Cell Endocrinol; 2011 Aug; 342(1-2):54-63. PubMed ID: 21664419
[TBL] [Abstract][Full Text] [Related]
17. Regulation of corticotropin-releasing factor receptor type 2beta mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells.
Kageyama K; Gaudriault GE; Suda T; Vale WW
Cell Signal; 2003 Jan; 15(1):17-25. PubMed ID: 12401516
[TBL] [Abstract][Full Text] [Related]
18. Localization of the type 1 corticotropin releasing factor receptor (CRF-R1) in the embryonic mouse cerebellum.
King JS; Bishop GA
J Neurocytol; 2003 Mar; 32(3):305-16. PubMed ID: 14724392
[TBL] [Abstract][Full Text] [Related]
19. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
Brar BK; Chen A; Perrin MH; Vale W
Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2.
Van Kolen K; Dautzenberg FM; Verstraeten K; Royaux I; De Hoogt R; Gutknecht E; Peeters PJ
Neuropharmacology; 2010 Jan; 58(1):135-44. PubMed ID: 19573542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
